BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1632479)

  • 1. A clinical index: a new method to assess efficacy of allergen immunotherapy.
    McHugh SM; Ewan PW
    Allergy; 1992 Apr; 47(2 Pt 1):115-20. PubMed ID: 1632479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.
    McHugh SM; Lavelle B; Kemeny DM; Patel S; Ewan PW
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):521-31. PubMed ID: 1699985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
    Varney VA; Tabbah K; Mavroleon G; Frew AJ
    Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
    Tari MG; Mancino M; Monti G
    Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
    J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite.
    Ewan PW; Alexander MM; Snape C; Ind PW; Agrell B; Dreborg S
    Clin Allergy; 1988 Sep; 18(5):501-8. PubMed ID: 3069238
    [TBL] [